Atypical Antiglomerular Basement Membrane Disease in a Pediatric Patient Successfully Treated with Rituximab

Area of Science:

• Nephrology
• Immunology
• Pediatric Nephrology

Background:

• Antiglomerular basement membrane (anti-GBM) disease is a rare, aggressive glomerulonephritis.
• Diagnosis typically involves linear immunoglobulin deposition and anti-GBM antibodies.

Observation:

• Atypical anti-GBM disease presents with indolent course, no pulmonary involvement, and rare antibody detection.
• A young child presented with hematuria and proteinuria, but normal creatinine.

Findings:

• The child's atypical anti-GBM disease was managed conservatively with steroids and rituximab.
• This treatment led to clinical symptom resolution and normalized laboratory values.

Implications:

• This case highlights a distinct presentation of anti-GBM disease in pediatric patients.
• Conservative management with steroids and rituximab may be effective for atypical anti-GBM disease in children.
• Further research is needed to establish clear treatment guidelines for this rare condition.